The utility of hematopoietic stem cell karyotyping in the diagnosis of de novo myelodysplastic syndromes.

MLA

Bandara, Manoj, et al. “The Utility of Hematopoietic Stem Cell Karyotyping in the Diagnosis of de Novo Myelodysplastic Syndromes.” Journal of Hematopathology, vol. 9, no. 3, Sept. 2016, pp. 121–28. EBSCOhost, https://doi.org/10.1007/s12308-016-0283-6.

APA

Bandara, M., Goonasekera, H., & Dissanayake, V. (2016). The utility of hematopoietic stem cell karyotyping in the diagnosis of de novo myelodysplastic syndromes. Journal of Hematopathology, 9(3), 121–128. https://doi.org/10.1007/s12308-016-0283-6

Chicago

Bandara, Manoj, Hemali Goonasekera, and Vajira Dissanayake. 2016. “The Utility of Hematopoietic Stem Cell Karyotyping in the Diagnosis of de Novo Myelodysplastic Syndromes.” Journal of Hematopathology 9 (3): 121–28. doi:10.1007/s12308-016-0283-6.